Intervention not reported
Adverse effects (1 day) · adults over the age of 50 with a unilateral transfemoral amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hernia recurrence · adults undergoing inguinal and femoral hernia repair
Mesh probably leads to lower hernia recurrence compared with non‐mesh repair (moderate certainty).
1 finding from 1 review
Surgical complications ‐ neurovascular or visceral injury · adults undergoing inguinal and femoral hernia repair
Mesh leads to lower surgical complications ‐ neurovascular or visceral injury compared with non‐mesh repair (high certainty).
1 finding from 1 review
Surgical complications ‐ wound infection · adults undergoing inguinal and femoral hernia repair
Mesh showed no clear difference in surgical complications ‐ wound infection compared with non‐mesh repair (low certainty).
1 finding from 1 review
Wound dehiscence · adults undergoing inguinal and femoral hernia repair
Mesh showed no clear difference in surgical complications ‐ wound dehiscence compared with non‐mesh repair (low certainty).
1 finding from 1 review
Mortality (within 30 days post‐surgery) · adults undergoing inguinal and femoral hernia repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Operating time · adults undergoing inguinal and femoral hernia repair
1 finding from 1 review
Length of postoperative hospital stay · adults undergoing inguinal and femoral hernia repair
1 finding from 1 review
Time to return to full ADLs (days) · adults undergoing inguinal and femoral hernia repair
1 finding from 1 review
Conversion to open surgery · adults undergoing inguinal and femoral hernia repair
1 finding from 1 review
Short‐term NACE · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower short‐term NACE compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term cardiac death · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower short‐term cardiac death compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term MI · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial showed no clear difference in short‐term MI compared with transfemoral approach (high certainty).
1 finding from 1 review
Success of the procedure · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower success of the procedure compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term all‐cause mortality · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial leads to lower short‐term all‐cause mortality compared with transfemoral approach (high certainty).
1 finding from 1 review
Bleeding · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial may leads to lower bleeding compared with transfemoral approach (low certainty).
1 finding from 1 review
Access site complications · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial may leads to lower access site complications compared with transfemoral approach (low certainty).
1 finding from 1 review
Relapse · patients with acute asthma
Intramuscular corticosteroids showed no clear difference in relapse compared with oral corticosteroids (low certainty).
3 findings from 1 review
RR 0.94 [0.72, 1.24]
9 studies · 804 participants
Low
RR 0.74 [0.51, 1.07]
7 studies · 742 participants
Moderate
RR 0.99 [0.74, 1.33]
5 studies · 556 participants
Low
Adverse events · patients with acute asthma
Intramuscular corticosteroids showed no clear difference in adverse events compared with oral corticosteroids (low certainty).
1 finding from 1 review
Health outcomes Peak expiratory flow readings (higher readings indicate better peak flow) · patients with acute asthma
1 finding from 1 review